You have 7 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

fam-trastuzumab deruxtecan-nxki

Showing 1 - 25 of 1,044
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Brain Cancer, Glioblastoma, Metastatic Cancer Trial in New York (Trastuzumab deruxtecan)

Recruiting
  • Brain Cancer
  • +4 more
  • Trastuzumab deruxtecan
  • New York, New York
    Memorial Sloan Kettering Cancer Center (All Protocol Activities)
Sep 22, 2023

Gastric Cancer Trial in Philadelphia (Neratinib Pill, Fam-Trastuzumab Deruxtecan-Nxki (TDxD))

Suspended
  • Gastric Cancer
  • Neratinib Pill
  • Fam-Trastuzumab Deruxtecan-Nxki (TDxD)
  • Philadelphia, Pennsylvania
    Fox Chase Cancer Center
Jul 6, 2022

Metastatic Malignant Solid Tumor, Unresectable Malignant Solid Tumor Trial in New Haven (procedure, drug, biological)

Recruiting
  • Metastatic Malignant Solid Neoplasm
  • Unresectable Malignant Solid Neoplasm
  • Biopsy
  • +2 more
  • Boston, Massachusetts
  • +2 more
Jan 25, 2023

HER2 Mutant NSCLC, HER2-positive Metastatic Breast Cancer, HER2 Gene Mutation Trial (ELVN-002, Fam-Trastuzumab Deruxtecan-Nxki,

Not yet recruiting
  • HER2 Mutant Non-small Cell Lung Cancer
  • +3 more
  • (no location specified)
Dec 6, 2022

Cancer, Advanced Solid Tumor Trial in Kettering (lorlatinib, encorafenib + binimetinib, talazoparib)

Recruiting
  • Cancer
  • Advanced Solid Tumor
  • Kettering, Ohio
    Kettering Health Network
Oct 14, 2022

Endometrial Serous Adenocarcinoma, Metastatic Malignant Solid Tumor, Unresectable Malignant Solid Tumor Trial in United States

Recruiting
  • Endometrial Serous Adenocarcinoma
  • +2 more
  • Biopsy
  • +3 more
  • Phoenix, Arizona
  • +3 more
Feb 2, 2023

Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Breast Carcinoma, Metastatic Malignant Tumor in the Brain Trial in Duarte

Recruiting
  • Anatomic Stage IV Breast Cancer AJCC v8
  • +2 more
  • Copper Cu 64-DOTA-Trastuzumab
  • +4 more
  • Duarte, California
    City of Hope Medical Center
Nov 22, 2022

Early-stage Breast Cancer, Hormone Receptor Positive Breast Carcinoma, Invasive Breast Cancer Trial in United States (drug,

Recruiting
  • Early-stage Breast Cancer
  • +6 more
  • Fullerton, California
  • +8 more
Sep 19, 2022

HER2-positive Breast Cancer, Metastatic Cancer, Metastatic Breast Cancer Trial in Chicago, Minneapolis (ALX148, Fam-Trastuzumab

Recruiting
  • HER2-positive Breast Cancer
  • +17 more
  • ALX148
  • Fam-Trastuzumab Deruxtecan-Nxki
  • Chicago, Illinois
  • +1 more
May 19, 2023

HER2-Positive Breast Carcinoma, Metastatic Malignant Solid Tumor, Refractory Malignant Solid Tumor Trial in United States

Recruiting
  • Advanced Malignant Solid Neoplasm
  • +4 more
  • Biopsy
  • +3 more
  • Bethesda, Maryland
  • +4 more
Jan 21, 2023

Osteosarcoma, Recurrent Osteosarcoma Trial in United States (Trastuzumab Deruxtecan)

Suspended
  • Osteosarcoma
  • Recurrent Osteosarcoma
  • Trastuzumab Deruxtecan
  • Birmingham, Alabama
  • +27 more
Oct 21, 2022

Breast Cancer Trial in Worldwide (Trastuzumab Deruxtecan)

Recruiting
  • Breast Cancer
  • Trastuzumab Deruxtecan
  • San Diego, California
  • +90 more
Jul 19, 2022

Invasive Breast Cancer, Inflammatory Breast Cancer Stage III, HER2-positive Breast Cancer Trial in Boston (Trastuzumab

Not yet recruiting
  • Invasive Breast Cancer
  • +4 more
  • Boston, Massachusetts
  • +1 more
Mar 20, 2023

Breast Cancer, Brain Metastases, Radiotherapy Trial in Shanghai (Combination use of SRT with T-DXd)

Not yet recruiting
  • Breast Cancer
  • +2 more
  • Combination use of SRT with T-DXd
  • Shanghai, China
    Fudan University Shanghai Cancer Center
Oct 14, 2023

HER2-positive Advanced Gastric Cancer, HER2-positive Gastroesophageal Junction Adenocarcinoma Trial (Trastuzumab deruxtecan)

Not yet recruiting
  • HER2-positive Advanced Gastric Cancer
  • HER2-positive Gastroesophageal Junction Adenocarcinoma
  • Trastuzumab deruxtecan
  • (no location specified)
Aug 11, 2023

Triple-Negative Breast Cancer Trial in Shanghai (Trastuzumab Deruxtecan)

Not yet recruiting
  • Triple-Negative Breast Cancer
  • Trastuzumab Deruxtecan
  • Shanghai, Shanghai, China
    Breast cancer institute of Fudan University Cancer Hospital
Jul 12, 2023

Breast Tumors, Breast Cancer, HER2-positive Early Breast Cancer Trial in Worldwide (Trastuzumab Deruxtecan, Paclitaxel,

Recruiting
  • Breast Neoplasms
  • +2 more
  • Trastuzumab Deruxtecan
  • +5 more
  • Springdale, Arkansas
  • +203 more
Jan 13, 2023

Breast Cancer Trial in Houston (Trastuzumab deruxtecan, Valemetostat)

Not yet recruiting
  • Breast Cancer
  • Houston, Texas
    M D Anderson Cancer Center
Dec 14, 2022

Breast Cancer Trial (Trastuzumab Deruxtecan)

Not yet recruiting
  • Breast Cancer
  • Trastuzumab Deruxtecan
  • (no location specified)
Jul 10, 2023

Metastatic Breast Cancer Trial in Worldwide (Trastuzumab deruxtecan, Durvalumab, Paclitaxel)

Recruiting
  • Metastatic Breast Cancer
  • Trastuzumab deruxtecan
  • +4 more
  • West Hollywood, California
  • +101 more
Jan 16, 2023

DESTINY Breast Respond HER2-low Europe

Not yet recruiting
  • Unresectable Breast Cancer
  • +2 more
  • Trastuzumab deruxtecan
  • (no location specified)
Jul 6, 2023

Locally Advanced Breast Cancer, Metastatic Breast Cancer Trial in Spain (Trastuzumab deruxtecan)

Not yet recruiting
  • Locally Advanced Breast Cancer
  • Metastatic Breast Cancer
  • Trastuzumab deruxtecan
  • Cádiz, Andalucía, Spain
  • +18 more
Feb 24, 2023

Gastrooesophageal Cancer Trial in United Kingdom (Trastuzumab deruxtecan)

Not yet recruiting
  • Gastrooesophageal Cancer
  • Trastuzumab deruxtecan
  • Southampton, Hampshire, United Kingdom
  • +16 more
Jul 27, 2023

Breast Cancer Stage IV Trial in Vienna (Trastuzumab deruxtecan)

Active, not recruiting
  • Breast Cancer Stage IV
  • Trastuzumab deruxtecan
  • Vienna, Austria
    AKH Universitaetsklinikum Vienna, Department f. Internal medicin
Jul 26, 2022

HER2-Positive Primary Breast Cancer, Residual Invasive Breast Cancer Trial in Worldwide (DS-8201a, T-DM1)

Recruiting
  • HER2-Positive Primary Breast Cancer
  • Residual Invasive Breast Cancer
  • Anaheim, California
  • +505 more
Feb 2, 2023